InvestorsObserver is giving Antares Pharma Inc (ATRS) an Analyst Rating Rank of 74, meaning ATRS is ranked higher by analysts than 74% of stocks. The average price target for ATRS is $6.571 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating ATRS a Strong Buy today. Find out what this means to you and get the rest of the rankings on ATRS!